{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:24:02Z","timestamp":1775183042444,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Roy and Joan Allen Professorship for Sight Research"},{"DOI":"10.13039\/100008459","name":"University of Calgary","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008459","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00415-024-12213-7","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T19:03:12Z","timestamp":1708110192000},"page":"2662-2671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Patterns and utility of myelin oligodendrocyte glycoprotein (MOG) antibody testing in cerebrospinal fluid"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0475-9535","authenticated-orcid":false,"given":"Jodie M.","family":"Burton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saerom","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Al-Ani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Costello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"12213_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, Probstel A-K, Aktas H, Alexopoulos H et al (2021) Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol 20:762\u2013772","journal-title":"Lancet Neurol"},{"issue":"13","key":"12213_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.885218","volume":"17","author":"E Sechi","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A, Lopez-Chiriboga AS, Pittock SJ, Flanagan EP (2022) Myelin Oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol 17(13):885218. https:\/\/doi.org\/10.3389\/fneur.2022.885218","journal-title":"Front Neurol"},{"issue":"3","key":"12213_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/wco.0000000000000681","volume":"32","author":"A Cobo-Calvo","year":"2019","unstructured":"Cobo-Calvo A, Vukusic S, Marignier R (2019) Clinical spectrum of central nervous system myelin oligodendrocyte glycoprotein autoimmunity in adults. Curr Opin Neurol 32(3):459\u2013466. https:\/\/doi.org\/10.1097\/wco.0000000000000681","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"12213_CR4","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","volume":"264","author":"S Mariotto","year":"2017","unstructured":"Mariotto S, Ferrari S, Monaco S et al (2017) Clinical spectrum and IgG subclass analysis of anti\u2014myelin oligodendrocyte glycoprotein antibody\u2014associated syndromes: a multicenter study. J Neurol 264(12):2420\u20132430. https:\/\/doi.org\/10.1007\/s00415-017-8635-4","journal-title":"J Neurol"},{"issue":"12","key":"12213_CR5","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/jamaneurol.2020.3115","volume":"77","author":"AS Lopez-Chiriboga","year":"2020","unstructured":"Lopez-Chiriboga AS, Sechi E, Buciuc M, Chen JJ, Pittock SJ, Lucchinetti CF, Flanagan EP (2020) Long-term outcomes in patients with myelin oligodendrocyte glycoprotein immunoglobulin G-associated disorder. JAMA Neurol 77(12):1575\u20131577. https:\/\/doi.org\/10.1001\/jamaneurol.2020.3115","journal-title":"JAMA Neurol"},{"key":"12213_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11737-8","author":"A Al-Ani","year":"2023","unstructured":"Al-Ani A, Chen JJ, Costello F (2023) Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges. J Neurol. https:\/\/doi.org\/10.1007\/s00415-023-11737-8. (Epub ahead of print)","journal-title":"J Neurol"},{"key":"12213_CR7","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2022.324","author":"JD Krett","year":"2022","unstructured":"Krett JD, Fritzler MJ, Alikhani K, Burton JM (2022) A quality assessment of aquaporin-4 & myelin oligodendrocyte glycoprotein antibody testing. Can J Neurol Sci. https:\/\/doi.org\/10.1017\/cjn.2022.324. (Epub ahead of print)","journal-title":"Can J Neurol Sci"},{"key":"12213_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103746","volume":"59","author":"M Levy","year":"2022","unstructured":"Levy M, Yeh EA, Hawkes CH, Lechner-Scott J, Giovannoni G (2022) Implications of low-titer MOG antibodies. Mult Scler Relat Disord 59:103746. https:\/\/doi.org\/10.1016\/j.msard.2022.103746. (Epub 2022 Mar 17)","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"12213_CR9","doi-asserted-by":"publisher","first-page":"e1095","DOI":"10.1212\/WNL.0000000000201662","volume":"100","author":"S Carta","year":"2023","unstructured":"Carta S, Cobo-Calvo \u00c1, Armangu\u00e9 T, Saiz A, Lechner C, Rost\u00e1sy K et al (2023) Significance of myelin oligodendrocyte glycoprotein antibodies in CSF: a retrospective multicenter study. Neurology 100(11):e1095\u2013e1108. https:\/\/doi.org\/10.1212\/WNL.0000000000201662","journal-title":"Neurology"},{"key":"12213_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad122","author":"Y Matsumoto","year":"2023","unstructured":"Matsumoto Y, Kaneko K, Takahashi T, Takai Y, Namatame C, Kuroda H et al (2023) Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids. Brain. https:\/\/doi.org\/10.1093\/brain\/awad122. (Epub ahead of print)","journal-title":"Brain"},{"issue":"3","key":"12213_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/jnnp-2021-326779","volume":"93","author":"S Pace","year":"2022","unstructured":"Pace S, Orrell M, Woodhall M, Palace J, Leite MI, Irani SR, Waters P, Handel AE (2022) Frequency of MOG-IgG in cerebrospinal fluid versus serum. J Neurol Neurosurg Psychiatry 93(3):334\u2013335. https:\/\/doi.org\/10.1136\/jnnp-2021-326779. (Epub 2021 Jul 14)","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12213_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP et al (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"key":"12213_CR13","doi-asserted-by":"publisher","first-page":"1192644","DOI":"10.3389\/fneur.2023.1192644","volume":"14","author":"TL Smith","year":"2023","unstructured":"Smith TL, Haven TR, Zuromski LM, Luong K, Clardy SL, Peterson LK (2023) High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting. Front Neurol 14:1192644. https:\/\/doi.org\/10.3389\/fneur.2023.1192644","journal-title":"Front Neurol"},{"issue":"1","key":"12213_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12974-020-01824-2","volume":"17","author":"S Jarius","year":"2020","unstructured":"Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, H\u00fcmmert MW, Ringelstein M et al (2020) in cooperation with the Neuromyelitis Optica Study Group (NEMOS). Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: results from 163 lumbar punctures in 100 adult patients. J Neuroinflammation 17(1):261. https:\/\/doi.org\/10.1186\/s12974-020-01824-2","journal-title":"J Neuroinflammation"},{"issue":"1","key":"12213_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12974-020-01825-1","volume":"17","author":"S Jarius","year":"2020","unstructured":"Jarius S, Lechner C, Wendel EM, Baumann M, Breu M, Schimmel M et al (2020) In cooperation with the BIOMARKER study group and the Neuromyelitis optica Study Group (NEMOS). Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients. J Neuroinflam 17(1):262. https:\/\/doi.org\/10.1186\/s12974-020-01825-1","journal-title":"J Neuroinflam"},{"issue":"1","key":"12213_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001095","volume":"9","author":"YN Kwon","year":"2021","unstructured":"Kwon YN, Kim B, Kim JS, Mo H, Choi K, Oh SI et al (2021) Myelin oligodendrocyte glycoprotein-immunoglobulin G in the CSF: clinical implication of testing and association with disability. Neurol Neuroimmunol Neuroinflamm 9(1):e1095. https:\/\/doi.org\/10.1212\/NXI.0000000000001095","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"12213_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/brain\/awl324","volume":"130","author":"HE Killer","year":"2007","unstructured":"Killer HE, Jaggi GP, Flammer J, Miller NR, Huber AR, Mironov A (2007) Cerebrospinal fluid dynamics between the intracranial and the subarachnoid space of the optic nerve. Is it always bidirectional. Brain 130(2):514\u2013520. https:\/\/doi.org\/10.1093\/brain\/awl324","journal-title":"Brain"}],"updated-by":[{"DOI":"10.1007\/s00415-024-12412-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000}}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12213-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12213-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12213-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T16:02:49Z","timestamp":1720195369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12213-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["12213"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12213-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00415-024-12412-2","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"29 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00415-024-12412-2","URL":"https:\/\/doi.org\/10.1007\/s00415-024-12412-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no relevant conflicts of interest of competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}